These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2100870)

  • 1. [Agonists and antagonists of the platelet activating factor (PAF). II].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(2):439-40. PubMed ID: 2100870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Agonists and antagonists of the platelet activating factor (PAF)].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):789-92. PubMed ID: 2636782
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of platelet activating factor and its antagonists in bronchial asthma].
    Massion PB; Frans A
    Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAF. A review of its effects, antagonists and possible future clinical implications (Part II).
    Koltai M; Hosford D; Guinot P; Esanu A; Braquet P
    Drugs; 1991 Aug; 42(2):174-204. PubMed ID: 1717219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of PAF antagonists in experimental models. Therapeutical perspectives].
    Desquand S
    Therapie; 1993; 48(6):585-97. PubMed ID: 8091344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to platelet-activating factor (PAF) inhibit PAF-induced platelet aggregation.
    Smal MA; Cooney SJ; Baldo BA
    J Lipid Mediat; 1991 Nov; 4(3):333-41. PubMed ID: 1764578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
    Hwang SB; Wang S
    Mol Pharmacol; 1991 Jun; 39(6):788-97. PubMed ID: 2051992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O; Robaut C; Cavero I
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor-induced calcium mobilization in human platelets and neutrophils: effects of PAF-acether antagonists.
    Selak MA; Smith JB
    J Lipid Mediat; 1989; 1(2):125-37. PubMed ID: 2519888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator.
    Hofmann B; Ostermann G; Hoffmann A; Klöcking HP; Kertscher HP
    Biomed Biochim Acta; 1988; 47(10-11):S157-60. PubMed ID: 3248103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
    Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
    J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor (PAF) antagonistic actions of two new analogs of tetrahydrofurans.
    Tsao PS; Stahl GA; Lefer AM; Salvino J; Pietranico S; Nicolaou KC
    J Lipid Mediat; 1989; 1(3):189-99. PubMed ID: 2519893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit blastocysts accumulate platelet-activating factor (PAF) and lyso-PAF in vitro.
    Jones MA; Kudolo GB; Harper MJ
    Mol Reprod Dev; 1992 Jul; 32(3):243-50. PubMed ID: 1323306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids.
    Mest HJ; Riedel A; Braquet P; Meyer E
    Biomed Biochim Acta; 1988; 47(10-11):S219-23. PubMed ID: 3248107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers.
    Hill ME; Bird IN; Daniels RH; Elmore MA; Finnen MJ
    J Immunol; 1994 Oct; 153(8):3673-83. PubMed ID: 7930587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
    Beauchamp MH; Marrache AM; Hou X; Gobeil F; Bernier SG; Lachapelle P; Abran D; Quiniou C; Brault S; Peri KG; Roberts J; Almazan G; Varma DR; Chemtob S
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3327-37. PubMed ID: 12356842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppression of platelet activating factor effects (PAF) on the retina by G-proteins inhibitors].
    Doly M; Oustrin J
    Ann Pharm Fr; 1996; 54(2):64-7. PubMed ID: 8734330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
    He J; Bazan HE
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.